|
CHP to offer expert consultative
advice for setting up medical device and pharma parks in UP
October 3, 2020
The Council for Healthcare and Pharma (CHP) will
offer expert consultative advice for the setting up of medical device and
pharmaceutical parks in the State of Uttar Pradesh, in line with the Prime
Minister’s vision for an Atmanirbhar Bharat.
"Government has rightly announced extensive
clustering programmes for bulk drugs/APIs as well as medical devices while
granting production-linked incentives to players – for APIs/bulk drugs as well
as select medical equipment. The production of APIs should be supported through
subsidised loans, capital subsidy, tax and duty exemption for import of capital
goods. On its part, the industry should explore the use of cheaper raw materials
for APIs,” Dr Gurpreet Sandhu, president, Council for Healthcare and Pharma
said.
The Council said that in terms of medical devices,
not only is there a need to shift from low-end devices to high end electronic
equipment, it is imperative that industry receives support by way of inexpensive
finance, minimum import duty on raw material and input equipment.
Sandhu added, “Although COVID has been a shocker to
the industry and policymakers in the short run, it will eventually prove to be a
positive stimulus. With India’s import vulnerabilities vis-à-vis China, a more
nationalistic trade policy with the underlying objectives of self-reliance
through import substitution and exports will drive the Indian pharma industry
forward.”
In view of a more stringent compliance regime in
the regulated markets and India’s large exposure overseas, the domestic quality
monitoring mechanism needs to be strengthened so that all-round quality goes up
adding to the competitive edge of Indian pharma products.
The Council for Healthcare and Pharma is a premier think tank committed to the
development of sustainable healthcare systems around the world. Founded in 2018,
the New Delhi headquartered not-for-profit health advocacy forum has a vision to
promote holistic healthcare and reduce the burden of global disease. With an
international footprint, it has reach in Africa, Brazil, China, France, Germany,
India, Japan, UK and USA.
With a view to facilitate knowledge exchange and
create seamless synergies involving the entire health ecosystem, CHP extensively
engages with health bodies, governments, pharma companies, medical device
manufacturers, health professionals, advocacy groups, research institutes,
health tech leaders, financiers and angel investors on a continuous basis.
http://pharmabiz.com/NewsDetails.aspx?aid=131528&sid=1
Indian Medical Device Industry,
growing faster during COVID-19 pandemic
October 01, 2020
goi-through-make-in-india-initiative-heavily-depends-rising-demand-essential-healthcare-equipment
As India geared up to fight the COVID-19 crisis,
the Association of Indian Medical Device Industry relentlessly worked at the
forefront to combat the crisis. Mr Rajiv Nath, Forum Coordinator, AiMED at the
behalf of the Indian Medical Device industry was in regular consultation with
the Govt & assured Commerce Minister, Shri Piyush Goyal & Govt. full support to
the Govt's spirited fight against COVID-19 crisis. Huge efforts were put into
increase medical manufacturing capacity by AiMeD through its Members and beyond
by reaching out to Garment Manufacturers, Automakers, Auto Component
Manufacturers and Electronic Component Manufacturers as preparedness for
possible unprecedented, unpredictable demands.
AiMeD is an Umbrella Association of Indian
Manufacturers of Medical Devices covering all types of Medical Devices including
Consumables, Disposables, Equipment’s, Instruments, Electronics, Diagnostics,
and Implants. With a Primary Membership of over 350 Manufacturers and
additionally of over 200 Associate Members representing the interest of over
1200 Manufacturers of Medical Devices, however, with over 2000 products AiMeD
should be over 7000 factories and bigger than Pharma to address the
manufacturer’s problems.
Mr Rajiv Nath recognized that the government
interventions under the able leadership of Cabinet Secretary, Shri Rajiv Gauba
and DOP Secretary, Dr P D Vaghela helped the Medical Devices industry scale up
production during the pandemic. AiMeD worked closely with Govt. of India i.e.
Dept. of Pharmaceuticals, Ministry of Commerce, NPPA & CDSCO etc. as a
Facilitator between the Govt. and the Manufacturers of Medical Devices e.g.
Gloves, Masks, Sanitizers, Ventilators, Diagnostic & Testing Kits for COVID-19
etc. for ramping up capacity and addressing Production bottlenecks in this
National Emergency to fight against COVID-19 pandemic during the complete
lockdown period.
AiMeD provided the Indian Govt., a single point of
contact access to Domestic Manufacturers and on behalf of Manufacturers provided
them various services like Advocacy on policy issues, Information services,
Regulations for Medical Devices, Education and Training services, Testing
Assistance and guidance for Quality Certification (ISO, CE, ICMED QMS), Lobbying
for funding for R&D from the Govt, encourage innovations from member units,
Improve clinician and patient access to the modern, innovative and reliable
Medical Device technologies through organizing and supporting Meetings,
Seminars, Symposia, Exhibitions and Demonstration, to promote global
harmonization and make India a MedTech superpower & also strengthen India to be
the 2nd factory in the world for Medical Devices & a dependable Manufacturer of
quality products in the global supply chain.
The Government of India through its flagship “Make
in India” initiative relied heavily on the Indian manufacturers to meet the
rising demand of essential healthcare equipment’s for the country, pushing the
Indian medical devices sector to become self-reliant especially for the
essential 39 COVID Medical Devices. AiMeD worked with QCI to expedite
finalization of ICMED Plus Certification as well as with Consultants Consortium
to provide online training on Quality Management System Certification to new
entrepreneurs from Automakers, Garments, Textile, Auto parts Industry who had
ventured into Medical Devices manufacturing to build capacity & capabilities to
meet QCIs ICMED Certification and Regulatory Compliance so that they could have
the confidence to seek Global Certification of CE and US FDA Compliance for
enabling Global Competitiveness. 4 batches of over 115 Manufacturers or their
representatives were intensely trained over 7 modules over 11 sessions spread
over 2 weeks in April & May 2020.
Before the outbreak of COVID-19, there were only 20
firms manufacturing 62 lacs PPE kits per year, but within two-three months, the
number of manufacturers listed with AiMeD increased to 140 with 25.55 Crore
annual capacity.
Similarly, the number of Indian firms
manufacturing, ventilator manufacturers went up from 8 to 17, mask manufacturers
from 30 to 108, swab manufacturers from zero to five and sanitizer manufacturers
from 35 to 49 and RT PCR Kit manufacturer from 0 to 8.
https://medicircle.in/goi-through-make-in-india-initiative-heavily-depends-rising-demand-essential-healthcare-equipment.
|
